A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma

Summary

The purpose of this study is to find out whether IMPRINT in combination with pembrolizumab is a safe treatment for people with malignant pleural mesothelioma (MPM).The highest dose of IMPRINT that causes few or mild side effects when given in combination with pembrolizumab will be found. Once the highest safe dose of IMPRINT is found, it will be tested in combination with pembrolizumab in future participants to see whether the combination may be an effective treatment for MPM.

Timeline

Start

2021-08-10

Primary completion

2026-08

Completion

2026-08

Drugs

Indications